Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT07718737 |
| Title | Global, Multicenter Study of AMT-116 Versus Investigator's Choice in Participants With Advanced or Metastatic Non-squamous EGFR-Wildtype Non-Small Cell Lung Cancer (NSCLC) With Progression on or After Platinum-Based Chemotherapy and Anti-PD-1/PD-L1 Immunotherapy |
| Recruitment | Not yet recruiting |
| Gender | both |
| Phase | Phase II |
| Variant Requirements | No |
| Sponsors | Multitude Therapeutics Inc. |
| Indications | |
| Therapies | |
| Age Groups: | senior | adult |
| Covered Countries | AUS |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| Coffs Harbour Health Campus | Coffs Harbour | Australia | Details | |||
| Austin Health (Olivia Newton John Cancer Centre) | Melbourne | Australia | Details | |||
| St Vincent's Hospital Melbourne | Melbourne | Australia | Details | |||
| Calvary Mater Newcastle | Newcastle | Australia | Details | |||
| Macquarie University Hospital | Sydney | Australia | Details |